Stock Market

Omicron-specific COVID vaccines on the horizon, Pfizer chief says

WASHINGTON (Reuters) – COVID-19 vaccines that specifically target the Omicron and other variants are under development, Pfizer Inc (NYSE:PFE)’s chief executive said on Wednesday, adding that the company will be able to quickly adapt shots as the novel coronavirus mutates.

While the ultimate approval decisions rest with U.S. regulatos, “we are ready for that,” the drugmaker’s CEO Albert Bourla told MSNBC in an interview, noting that the Food and Drug Administration is convening a meeting later this month.


Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

fourteen − nine =

Back to top button